An underlying principle of public health is, or was, to provide the public with accurate information so that they can make good health choices for themselves and their community.
The past 3 years have seen this paradigm turned on its head, with the public’s money being used to deceive and coerce them, forcing them to follow public health dictates. The public has funded their own incarceration and impoverishment through their taxes, with public funds driving the unprecedented nonpharmaceutical, and then pharmaceutical, response to a virus that kills mainly old sick people near the end of their lives.
Children have had their education downgraded, and economies have been mangled, ensuring future generations will also pay. So, what did the public actually pay for? (…)
Governments take over medical management
Early in the pandemic it became clear that intubating a COVID-19 patient could increase long-term harm and mortality. Unfortunately, many hospitals continued a low threshold for the use of ventilators for the fear that other methods of oxygenation would spread the virus. In 2020 the US spent billions of dollars stockpiling unused ventilators.
In many countries a relatively new antiviral drug, remdesivir, developed with State funding, became the first choice of treatment for hospitalized people with COVID-19. The safety and toxicity of the expensive remdesivir was widely disputed. Yet even after the first results of the WHO’s Solidarity study found little or no effect on reducing hospital stay or Covid deaths, the EU continued a €1.2 billion agreement with Gilead for 500,000 treatments and it continued to be prioritized for use in the United States.
Final results of the Solidarity study confirmed the finding of little or no effect. In contrast, the use of cheaper drugs with antiviral activity, like ivermectin and hydroxychloroquine, was suppressed. Although ivermectin is now included in lists of the US National Institutes of Health in August 2022, governments are silent on its use, preferring to transfer funds to Pharma for newer on-patent drugs. (…)
The current COVID-19 response has wiped out the gains from decades of global progress in health and income, especially for women and has exacerbated persistent inequities. Unfortunately, a world that is facing the most serious health crisis in a century and the most serious economic and social crises since the second World War is now also on the hook to fund those who would repeat this.
Together with the WHO, world leaders have now called for a global pandemic preparedness treaty to make this state of affairs more readily repeatable. They justify this call for further diversion of public funds through the harms, financial and other, accrued during the COVID-19 outbreak.
This is driven by a vision that health is a political choice based on solidarity and ‘equity’ to be established in a centralized global response delivered via international organizations including the WHO, UNICEF, Gavi, (a global Vaccine Alliance) and the public-private partnership Coalition for Economic Preparedness Information (CEPI), launched in 2017 at the WEF by Bill Gates, the Wellcome Trust, Norwegian Government and others. Finance institutions, including the World Bank, have now stepped in to accelerate the growth of this burgeoning pandemic industry. A new World Bank-hosted Financial Intermediary Fund (FIF) for pandemic prevention, preparedness and response was installed at the G20 Health Ministerial Meeting in June 2022.
A real concern is growing that the new vision of drug and vaccine approval by the FDA and EMA will expand a commercialized market driven by drug manufacturers at the expense of rigorous independent scientific and regulatory review. This risks irreparable harm for many people while boosting the profits of pharmaceutical and biotech companies. Prescribed medications are already estimated to be the third most common contributor to death globally after heart disease and cancer.
Read the full article here: A Big Picture Look at the Disastrous Public Health Response to COVID-19